October 30, 2014 Positive Phase II preliminary results of Validive® for the prevention of Severe Oral Mucositis in Head and Neck cancer patients
October 13, 2014 Nexstim launches its Initial Public Offering and will apply for dual listing on Nasdaq First North Finland and Nasdaq First North Sweden
October 02, 2014 Nexstim Supports 6th International Symposium on Navigated Brain Stimulation in Neurosurgery
September 29, 2014 Aerocrine AB and Microsoft collaborate to test secure, cloud-based remote medical device monitoring.